Edition:
United States

UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

240JPY
12:45am EDT
Change (% chg)

¥1 (+0.42%)
Prev Close
¥239
Open
¥244
Day's High
¥248
Day's Low
¥239
Volume
257,200
Avg. Vol
787,274
52-wk High
¥2,420
52-wk Low
¥225

4585.T

Chart for 4585.T

About

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal... (more)
No analyst recommendations are available for 4585.T.

Overall

Beta: 2.75
Market Cap(Mil.): ¥2,939.36
Shares Outstanding(Mil.): 12.20
Dividend: --
Yield (%): --

Financials

  4585.T Industry Sector
P/E (TTM): -- 58.01 30.10
EPS (TTM): -1,259.04 -- --
ROI: -6,104.33 0.27 13.21
ROE: -- 6.15 14.37

BRIEF- UMN Pharma cancels business cooperation agreements with API and Yakult Honsha

* Says it terminated three business cooperation agreements with API Co Ltd and Yakult Honsha Company, Limited

Mar 31 2017

BRIEF-UMN Pharma sells entire 50 pct stake in bio-pharma firm UNIGEN

* Says the co sold entire 50 percent stake in bio-pharma firm UNIGEN

Jan 31 2017

BRIEF-Astellas terminates agreement with UMN Pharma for cell culture based influenza vaccine programs

* Says co terminates agreement with UMN Pharma Inc , for the co-development and Astellas' exclusive commercialization of ASP7374 and ASP7373, the cell culture based influenza vaccine programs in Japan

Jan 10 2017

BRIEF-UMN Pharma announces exercise of options

* Says 150,000 units of its 20 series options were exercised to 150,000 shares of its common stock on Jan. 6

Jan 06 2017

More From Around the Web

Earnings vs. Estimates